.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Deloitte
Baxter
Farmers Insurance
US Army
Argus Health
Merck
Chubb
Colorcon

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090432

« Back to Dashboard
NDA 090432 describes ESCITALOPRAM OXALATE, which is a drug marketed by Invagen Pharms, Macleods Pharms Ltd, Sti Pharma Llc, Amneal Pharms, Hetero Labs Ltd Iii, Taro, Aurobindo Pharma Ltd, Prinston Inc, Zydus Pharms Usa Inc, Torrent Pharms Ltd, Mylan Pharms Inc, Teva Pharms Usa, Hikma Pharms, Antrim Pharms Llc, Lupin Ltd, Silarx Pharms Inc, Apotex Inc, Jubilant Generics, and Accord Hlthcare, and is included in twenty-three NDAs. It is available from fifty-three suppliers. Additional details are available on the ESCITALOPRAM OXALATE profile page.

The generic ingredient in ESCITALOPRAM OXALATE is escitalopram oxalate. There are twenty-five drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.

Summary for NDA: 090432

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidepressants
Anxiolytics

Pharmacology for NDA: 090432

Mechanism of ActionSerotonin Uptake Inhibitors

Suppliers and Packaging for NDA: 090432

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL 090432 ANDA PD-Rx Pharmaceuticals, Inc. 43063-666 43063-666-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-666-01)
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL 090432 ANDA PD-Rx Pharmaceuticals, Inc. 43063-666 43063-666-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-666-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Sep 11, 2012TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Sep 11, 2012TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Sep 11, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Dow
Fish and Richardson
Medtronic
Deloitte
Covington
Julphar
Cipla
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot